PortfoliosLab logoPortfoliosLab logo
BBC vs. FHLC
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

BBC vs. FHLC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Virtus LifeSci Biotech Clinical Trials ETF (BBC) and Fidelity MSCI Health Care Index ETF (FHLC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BBC achieves a 27.03% return, which is significantly higher than FHLC's 6.71% return. Both investments have delivered pretty close results over the past 10 years, with BBC having a 9.38% annualized return and FHLC not far ahead at 9.77%.


BBC

1D
0.50%
1M
-7.22%
6M
16.85%
YTD
27.03%
1Y
132.20%
3Y*
29.78%
5Y*
2.55%
10Y*
9.38%
ALL TIME*
6.30%

FHLC

1D
-0.04%
1M
-1.19%
6M
6.28%
YTD
6.71%
1Y
27.87%
3Y*
9.42%
5Y*
4.81%
10Y*
9.77%
ALL TIME*
10.71%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$614.18K$1.46M$1.24M
$13.38M$17.91M$16.14M

BBC vs. FHLC - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
BBC
Virtus LifeSci Biotech Clinical Trials ETF
27.03%63.77%-1.11%-1.80%-35.13%-22.31%30.32%63.81%-18.29%57.85%
FHLC
Fidelity MSCI Health Care Index ETF
6.71%15.42%2.48%2.58%-5.55%20.39%18.13%21.94%4.71%23.34%

Correlation

The correlation between BBC and FHLC is 0.44, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.44

Correlation (3Y)
Balances recent behavior with more history.

0.50

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.54

Correlation (10Y)
Provides a long-term view across more market conditions.

0.58

Correlation (All Time)
Calculated using the full available price history since Dec 17, 2014

0.61

The correlation between BBC and FHLC shifts across timeframes, from 0.44 (1 year) to 0.61 (all time), reflecting how their relationship changes across market environments.

BBC vs. FHLC - Sectors Allocation Comparison


Sectors
BBC
FHLC

Healthcare

100.0%
98.9%

Financial Services

0.8%
0.0%

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Industrials

-

0.0%

Real Estate

-

-

Technology

-

0.4%

Utilities

-

-

Healthcare

BBC
100.0%
FHLC
98.9%

Financial Services

BBC
0.8%
FHLC
0.0%

Basic Materials

BBC

-

FHLC

-

Communication Services

BBC

-

FHLC

-

Consumer Cyclical

BBC

-

FHLC

-

Consumer Defensive

BBC

-

FHLC

-

Energy

BBC

-

FHLC

-

Industrials

BBC

-

FHLC
0.0%

Real Estate

BBC

-

FHLC

-

Technology

BBC

-

FHLC
0.4%

Utilities

BBC

-

FHLC

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BBC vs. FHLC — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

BBC
BBC Risk / Return Rank: 9696
Overall Rank
BBC Sharpe Ratio Rank: 9797
Sharpe Ratio Rank
BBC Sortino Ratio Rank: 9595
Sortino Ratio Rank
BBC Omega Ratio Rank: 9393
Omega Ratio Rank
BBC Calmar Ratio Rank: 9898
Calmar Ratio Rank
BBC Martin Ratio Rank: 9696
Martin Ratio Rank

FHLC
FHLC Risk / Return Rank: 7474
Overall Rank
FHLC Sharpe Ratio Rank: 7979
Sharpe Ratio Rank
FHLC Sortino Ratio Rank: 8585
Sortino Ratio Rank
FHLC Omega Ratio Rank: 7575
Omega Ratio Rank
FHLC Calmar Ratio Rank: 7575
Calmar Ratio Rank
FHLC Martin Ratio Rank: 5555
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

BBC vs. FHLC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Clinical Trials ETF (BBC) and Fidelity MSCI Health Care Index ETF (FHLC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


BBCFHLCDifference
Sharpe ratioReturn per unit of total volatility

+1.80

Sortino ratioReturn per unit of downside risk

+1.22

Omega ratioGain probability vs. loss probability

1.48

1.32

+0.16

Calmar ratioReturn relative to maximum drawdown

8.81

2.70

+6.11

Martin ratioReturn relative to average drawdown

23.93

6.71

+17.22

BBC vs. FHLC - Sharpe Ratio Comparison

The current BBC Sharpe Ratio is 3.65, which is higher than the FHLC Sharpe Ratio of 1.85. The chart below compares the historical Sharpe Ratios of BBC and FHLC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

BBC vs. FHLC - Drawdown Comparison

The maximum BBC drawdown since its inception was -76.85%, which is greater than FHLC's maximum drawdown of -28.76%. Use the drawdown chart below to compare losses from any high point for BBC and FHLC.


Loading charts...

Drawdown Indicators


BBCFHLCDifference

Max Drawdown

Largest peak-to-trough decline

-76.85%

-28.76%

-48.09%

Max Drawdown (1Y)

Largest decline over 1 year

-15.10%

-10.38%

-4.72%

Max Drawdown (3Y)

Largest decline over 3 years

-54.45%

-16.87%

-37.58%

Max Drawdown (5Y)

Largest decline over 5 years

-70.92%

-17.73%

-53.19%

Max Drawdown (10Y)

Largest decline over 10 years

-76.85%

-28.76%

-48.09%

Current Drawdown

Current decline from peak

-18.46%

-2.81%

-15.65%

Average Drawdown

Average peak-to-trough decline

-36.87%

-5.16%

-31.71%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.55%

4.16%

+1.39%

Volatility

BBC vs. FHLC - Volatility Comparison

Virtus LifeSci Biotech Clinical Trials ETF (BBC) has a higher volatility of 10.19% compared to Fidelity MSCI Health Care Index ETF (FHLC) at 4.94%. This indicates that BBC's price experiences larger fluctuations and is considered to be riskier than FHLC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BBCFHLCDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.19%

4.94%

+5.25%

Volatility (6M)

Calculated over the trailing 6-month period

26.25%

11.69%

+14.56%

Volatility (1Y)

Calculated over the trailing 1-year period

36.52%

15.17%

+21.35%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

39.61%

15.25%

+24.36%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

37.72%

16.90%

+20.82%

BBC vs. FHLC - Expense Ratio Comparison

BBC has a 0.79% expense ratio, which is higher than FHLC's 0.08% expense ratio.


Dividends

BBC vs. FHLC - Dividend Comparison

BBC's dividend yield for the trailing twelve months is around 1.34%, more than FHLC's 1.30% yield.


PositionTTM20252024202320222021202020192018201720162015
BBC
Virtus LifeSci Biotech Clinical Trials ETF
1.34%1.70%1.00%0.34%0.00%0.00%0.00%0.00%0.00%2.09%0.00%0.51%
FHLC
Fidelity MSCI Health Care Index ETF
1.30%1.40%1.51%1.40%1.30%1.16%1.45%1.18%1.38%1.38%1.40%2.07%

Frequently Asked Questions


BBC and FHLC have a correlation of 0.44, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BBC has higher volatility (10.19%) compared to FHLC (4.94%). In terms of maximum drawdown, BBC dropped -76.85% vs FHLC's -28.76%.

On 10-year performance, FHLC leads with 9.77% vs 9.38% for BBC. On fees, FHLC is cheaper at 0.08% per year. On volatility, FHLC has been the lower-risk option at 4.94%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, FHLC has performed better with a 9.77% return vs 9.38%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

FHLC is cheaper with a 0.08% expense ratio, compared with 0.79% for BBC.

BBC has the higher dividend yield at 1.34%, compared with 1.30% for FHLC.

BBC tracks LifeSci Biotechnology Clinical Trials Index, while FHLC tracks MSCI USA IMI Health Care Index. They also come from different issuers: Virtus and Fidelity. Their fees differ too: 0.79% for BBC and 0.08% for FHLC.

BBC currently has the higher Sharpe Ratio (3.65 vs 1.85), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for BBC and FHLC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer